Cirrhosis Patient Survival Prediction
Utilize 17 clinical features for predicting survival state of patients with liver cirrhosis. The survival states include 0 = D (death), 1 = C (censored), 2 = CL (censored due to liver transplantation).
Characteristics
Subject Area
Associated Tasks
Attribute Type
# Instances
# Attributes
Info
During 1974 to 1984, 424 PBC patients referred to the Mayo Clinic qualified for the randomized placebo-controlled trial testing the drug D-penicillamine. Of these, the initial 312 patients took part in the trial and have mostly comprehensive data. The remaining 112 patients didn't join the clinical trial but agreed to record basic metrics and undergo survival tracking. Six of these patients were soon untraceable after their diagnosis, leaving data for 106 of these individuals in addition to the 312 who were part of the randomized trial.
Introductory Paper
Prognosis in primary biliary cirrhosis: Model for decision making
By E. Dickson, P. Grambsch, T. Fleming, L. Fisher, A. Langworthy. 1989
Provided by
University of California, Irvine
Creators
- E. Dickson
- P. Grambsch
- T. Fleming
- L. Fisher
- A. Langworthy
DOI
Create an account!
Features
Attribute Name | Role | Type | Demographic | Description | Units | Missing Values |
---|---|---|---|---|---|---|
ID | ID | Integer | unique identifier | no | ||
N_Days | Other | Integer | number of days between registration and the earlier of death, transplantation, or study analysis time in July 1986 | no | ||
Status | Target | Categorical | status of the patient C (censored), CL (censored due to liver tx), or D (death) | no | ||
Drug | Feature | Categorical | type of drug D-penicillamine or placebo | yes | ||
Age | Feature | Integer | Age | age | days | no |
Sex | Feature | Categorical | Sex | M (male) or F (female) | no | |
Ascites | Feature | Categorical | presence of ascites N (No) or Y (Yes) | yes | ||
Hepatomegaly | Feature | Categorical | presence of hepatomegaly N (No) or Y (Yes) | yes | ||
Spiders | Feature | Categorical | presence of spiders N (No) or Y (Yes) | yes | ||
Edema | Feature | Categorical | presence of edema N (no edema and no diuretic therapy for edema), S (edema present without diuretics, or edema resolved by diuretics), or Y (edema despite diuretic therapy) | no | ||
Bilirubin | Feature | Continuous | serum bilirubin | mg/dl | no | |
Cholesterol | Feature | Integer | serum cholesterol | mg/dl | yes | |
Albumin | Feature | Continuous | albumin | gm/dl | no | |
Copper | Feature | Integer | urine copper | ug/day | yes | |
Alk_Phos | Feature | Continuous | alkaline phosphatase | U/liter | yes | |
SGOT | Feature | Continuous | SGOT | U/ml | yes | |
Tryglicerides | Feature | Integer | tryglicerides | yes | ||
Platelets | Feature | Integer | platelets per cubic | ml/1000 | yes | |
Prothrombin | Feature | Continuous | prothrombin time | s | yes | |
Stage | Feature | Categorical | histologic stage of disease (1, 2, 3, or 4) | yes |